What is TERN-101 used for?

TERN-101 is being researched as a potential treatment for non-alcoholic steatohepatitis (NASH).

Is TERN-101 an approved drug?

No, TERN-101 is an experimental small molecule currently in clinical development phases.

What kind of condition does TERN-101 target?

It is being studied for its effects on non-alcoholic fatty liver disease.

Is TERN-101 safe to use?

Because TERN-101 is still in clinical testing, its full safety profile and side effects are not yet established for public use.

What is the chemical structure of TERN-101?

TERN-101 is a small molecule with the chemical formula C28H27Cl2N3O4.

How far along is TERN-101 in medical testing?

TERN-101 is currently in phase 2 of clinical research.

EX-A2794 | CAS 1103500-20-4 | RPVDFHPBGBMWID

Loading compound...

Experimental small molecule

TERN-101 is an experimental small molecule currently being studied in clinical research. It is being investigated for its potential to treat non-alcoholic steatohepatitis (NASH), a type of fatty liver disease.

How it worksTERN-101 is a small molecule being researched for its ability to target biological processes related to non-alcoholic fatty liver disease.

Used for

non-alcoholic steatohepatitis (NASH)

Conditions

non-alcoholic steatohepatitisNon-alcoholic Fatty Liver Disease

Class

Small moleculeExperimental small moleculeHepatic

How to take

This substance is currently in the research phase (max phase 2) and is not an approved medication for general use.

Talk to your doctor

Questions to ask

·Is TERN-101 part of any clinical trials for my liver condition?
·What are the expected side effects of TERN-101 in research settings?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)